CompletedNCT05892432
Oral semaglutide and alcohol use: randomized study
About this title
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
Read the official source — NCT05892432Medication studyAges 21+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 21 years.
- Listed locations
- AuroraSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 11, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT05892432
- Official title
Show the full official title
Randomized, Controlled Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Aurora
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Denver, a university.
Did this study involve medication?
Yes. The study involved medication, including Semaglutide 3 MG [Rybelsus], Semaglutide 7 MG [Rybelsus] and Placebo.
Who was this study for?
Listed age limits: from 21 years.
